230. 肺胞低換気症候群 [臨床試験数:8,薬物数:11(DrugBank:5),標的遺伝子数:18,標的パスウェイ数:27

Searched query = "Alveolar hypoventilation syndrome", "AHS", "Hypoventilation syndrome", "OHS", "CCHS", "Idiopathic central alveolar hypoventilation", "ICAH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01500473February 201222/12/2011Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation SyndromeTherapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation SyndromeCongenital Central Hypoventilation SyndromeDrug: DesogestrelChildren's Hospital Los AngelesNULLNot yet recruiting16 Years50 YearsFemale8N/AUnited States
2NCT01243697April 201117/11/2010Assessment of Desogestrel in Ondine SyndromeAssessment of Desogestrel for a Pharmacological Recovery of Ventilatory Activity in Congenital Central Hypoventilation Syndrome - Ondine SyndromeOndine SyndromeDrug: desogestrelAssistance Publique - Hôpitaux de ParisNULLCompleted10 Years60 YearsFemale6Phase 2/Phase 3France
3EUCTR2011-000989-35-FR06/05/2011N/AN/A - RESPIRONDINE
MedDRA version: 14.0Level: PTClassification code 10066131Term: Congenital central hypoventilation syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
Trade Name: Cerazette
Product Name: Cerazette
INN or Proposed INN: Désogestrel
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)NULLNAFemale: yes
Male: no
Phase 2France